Press release
Global Liver Cancer Treatment Market Trends | Segmentation, Outlook, Industry Report to 2021-2027
The global liver cancer treatment market is anticipated to grow at a CAGR of 10.2% during the forecast period (2021-2027). The rising change in lifestyle of people such as consumption of alcohol, rising prevalence of liver cancer cases, increasing awareness for the treatment of cancer, and rising FDA approvals, are driving the liver cancer treatment market during the forecast period. For instance, according to the WHO data, globally, in 2020, there were around 905,677 (4.7%) new liver cancer cases and 830,180 (8.3%) deaths due to liver cancer.(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/liver-cancer-treatment-market
In March 2020, the US Food and Drug Administration (FDA) has approved Bristol Myers Squibb's liver cancer drug combination. Patients with hepatocellular carcinoma (HCC), one of the most aggressive and widespread forms of liver cancer, will receive the Opdivo (nivolumab) plus Yervoy (ipilimumab) drug treatment. Apart from it, in March 2020, Dicerna Pharmaceuticals, Inc., a developer of investigational ribonucleic acid interference (RNAi) therapeutics, has announced that it has received the US FDA approval for orphan drug designation (ODD) to Dicerna's DCR-A1AT for the treatment of alpha-1 antitrypsin (A1AT) deficiency. A1AT deficiency is a hereditary condition that can lead to lung and liver disease. Children with the disease's liver manifestations may experience jaundice (yellowing of the skin and whites of the eyes) and scar tissue formation in the liver (cirrhosis). Adults with liver disease can develop cirrhosis, progress to liver failure, or develop hepatocellular carcinoma, a form of liver cancer.
A Full Report of Global Liver Cancer Treatment Market is Available at: https://www.omrglobal.com/industry-reports/liver-cancer-treatment-market
Furthermore, in December 2018, AVEO Oncology has announced a partnership with AstraZeneca to evaluate the efficacy of the company’s drugs. In a Phase 1/2 trial, AstraZeneca's IMFINZI (durvalumab), a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1), was used in conjunction with AVEO's FOTIVDA(tivozanib), an oral, and highly-selective vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) in first-line hepatocellular carcinoma (HCC), or liver cancer. However, the demand for the treatment of cancers, new drugs, FDA approvals, and device launches, and the increasing prevalence of cancer patients could impede the global liver cancer diagnosis and treatment market over the coming years.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Liver Cancer Treatment Market Report Segment
By Treatment
Liver Cancer Surgery
Tumor Ablation
Embolization Therapy
Radiation Therapy
Targeted Therapy
Immunotherapy
Chemotherapy
By End-User
Hospitals & Clinics
Research Centers
Global Liver Cancer Treatment Market Report Segment by Region
North America
US
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Reasons to Buying From us –
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/liver-cancer-treatment-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Liver Cancer Treatment Market Trends | Segmentation, Outlook, Industry Report to 2021-2027 here
News-ID: 2312931 • Views: …
More Releases from Orion Market Research
Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Lead …
The Global Digital Innovation in Insurance Market is projected to reach around USD 250 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 9.5% from 2024 to 2033.
Digital Innovation in Insurance Market Overview
The Digital Innovation in Insurance Market encompasses the integration of advanced technologies such as Artificial Intelligence (AI), Blockchain, the Internet of Things (IoT), and Big Data analytics into the insurance sector. These innovations are…
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
The Global Cigarette Rolling Paper Market was valued at approximately USD 2.9 billion in 2024 and is projected to reach around USD 41.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 34.5% from 2024 to 2033.
Cigarette Rolling Paper Market Overview
The Global Cigarette Rolling Paper Market has experienced significant growth, driven by increasing consumer preference for hand-rolled cigarettes, particularly among younger and budget-conscious smokers. These papers…
Back Glue Market: Emerging Trends and Growth Forecast to 2033
The Global Back Glue Market is projected to reach around USD 3.0 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 7.1% from 2024 to 2033.
Back Glue Market Overview
The Global Back Glue Market encompasses adhesives designed for various applications, including bookbinding, phone back panels, and other industrial uses. Advancements in technology have led to the development of high-performance back glue adhesives, which are anticipated to drive…
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
The Global Autopilot Systems Market was valued at approximately USD 5.8 billion in 2023 and is projected to reach around USD 10.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 6.4% from 2024 to 2033.
Autopilot Systems Market Overview
The Global Autopilot Systems Market encompasses advanced flight control systems designed to automate the navigation and operation of aircraft, reducing the need for manual input by pilots. These…
More Releases for FDA
DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes…
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming
CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility…
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug…
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30).
Announcing New Design Control Training Courses
Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a…
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation.
GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet…
FDA online training
Description:
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding…
